Abstract: A cosmetic preparation which comprises one or more selected perfume substances and one or more glucosyl glycerides.

Abstract: Cosmetic preparation containing a combination of a) urea and b) one or more glucosyl glycerides.

Abstract: Active ingredient combinations of one or more glucosyl glycerides and one or more substances selected from creatine, creatinine, creatine phosphate, creatine sulfate, creatine acetate, creatine ascorbate, and creatine derivatives whose carboxyl group is esterified by a mono- or polyfunctional alcohol, and cosmetic preparations comprising these active ingredient combinations.

Abstract: The development relates to cosmetic and dermatological preparations containing aquaporin stimulators, in particular glyceryl glycosides, and their use to improve the moisturizing of the skin.

Abstract: The invention relates to oligoribonucleotides, which are capable of inducing breakdown of the mrna enzymes that break down connective tissue, and to pharmaceutical and cosmetic compositions, which are provided for topical application and which contain the oligoribonucleotides. The compositions are particularly suited for treating degenerative skin disorders.

Abstract: A cosmetic preparation which comprises an active complex of panthenol, glycerol and citrate. The mass ratio of panthenol to citrate anion is from 25:1 to 5:1 and the preparation has a pH value of from 4.6 to 5.4 and an SCTE (Stratum Corneum Tryptic Enzyme) value of from 120 to 170.

Abstract: Use of licochalcone A or of an extract containing licochalcone A from Radix Glycyrrhizae inflatae in cosmetic and dermatological preparations for the treatment and prophylaxis of the symptoms of intrinsic and/or extrinsic skin ageing and the treatment and prophylaxis of the damaging effects of ultraviolet radiation on the skin.

Abstract: Cosmetic and/or dermatological preparation containing one or more 2,3-dibenzylbutyrolactone derivatives and/or their glycosides besides optionally additional cosmetic and/or dermatological active ingredients, auxiliary agents, and additives.

Abstract: Described are a novel marker protein associated with apithelial tumors, TAP-70, belonging to the family of aspartyl proteinases and nucleic acid molecules encoding TAP-70 polypeptides. Moreover, diagnostic and therapeutic uses based on the finding that TAP-70 is overexpressed throughout skin carcinogenesis are described.

Abstract: The invention relates to oligoribonucleotides, which are capable of inducing breakdown of the mRNA enzymes that break down connective tissue, and to pharmaceutical and cosmetic compositions, which are provided for topical application and which contain the oligoribonucleotides. The compositions are particularly suited for treating degenerative skin disorders.

Abstract: A pharmaceutical or cosmetic composition for topical application containing one or more oligonucleotides which are capable of hybridizing with a mRNA or a gene sequence which codes for a connective-tissue decomposing enzyme, or a physiologically compatible salt thereof. The compositions are suitable in particular for the treatment of degenerative skin conditions.

Abstract: The invention is a double-stranded oligoribonucleotide or a physiologically compatible salt thereof, which is capable of inducing the degradation of mRNA of one of more structures involved in inflammation or irritation of the skin. The invention is also cosmetic or therapeutic compositions comprising one or more such double-stranded oligoribonucleotide and methods of treatment by use thereof.

Abstract: The invention is a cosmetic or dermatological preparation comprising taurine and at least one substance selected from the group consisting of phytosterols, ceramides, long-chain fatty acids, and cholesterol. The invention also includes a method of strengthening the skin barrier comprising applying to the skin a preparation comprising taurine and at least one substance selected from the group consisting of phytosterols, ceramides, long-chain fatty acids, and cholesterol. The invention also includes methods of moisturizing the skin, improving the microtopography of the skin, improving the elasticity of the skin, treating or preventing functional disorders of skin appendages, treating or preventing the symptoms of skin ageing, and treating or preventing the harmful effects of ultraviolet radiation on the skin comprising applying the preparation.

Abstract: The invention is a cosmetic or dermatological preparation comprising at least one reaction product of DNA selected from the group consisting of oxidation products of mononucleosides, oxidation products of nucleobases, photoproducts of mononucleosides, and photoproducts of nucleobases. In one embodiment, the invention includes a cosmetic or dermatological preparation comprising at least one 8-hydroxypurine nucleoside. The invention also includes methods for preventing or treating degenerative or inflammatory skin symptoms, reducing skin wrinkles, preventing skin aging or firming the skin comprising applying the cosmetic or dermatological preparation to the skin, optionally in combination with laser or abrasive treatment.